Nexstim Receives an NBS 5+ System Order from Seattle Children's Hospital
globenewswire.com
news
2022-06-02 00:00:00

Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children's Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today announced it has received an NBS 5+ system order from Seattle Children's in the United States. The Nexstim NBS 5+ system, released in 2021, gives customers access to the software of both Nexstim's NBS (Navigated Brain Stimulation) and NBTÂ® (Navigated Brain Therapy) systems. This means that the system can be used for both neurosurgical mapping and treatment of major depressive disorder (MDD).
